ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenDISCO Pharmaceuticals Swiss GmbH
DISCO Pharmaceuticals Swiss GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

DISCO Pharmaceuticals Swiss GmbH applies a surfaceome mapping platform to identify cell-surface proteins and protein communities, providing molecular targets for antibody-based cancer therapies. Its initial discovery programs focus on small cell lung cancer and microsatellite-stable colorectal cancer, supporting candidate generation for mono- and bispecific antibodies and antibody–drug conjugates.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

DISCO Pharmaceuticals Swiss GmbH

✓ Offered2
Target Discovery Platform
Surfaceome mapping platform for identifying novel cell-surface targets, protein communities and target candidates for mono-specific and bi-specific antibodies.
Oncology Drug Discovery Programme
Discovery and development of cancer therapeutics for Small Cell Lung Cancer and microsatellite-stable colorectal cancer, with other tumour types in development.
Trust & reputation

ranQ Trust Score of DISCO Pharmaceuticals Swiss GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

DISCO Pharmaceuticals Swiss GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
DISCO Pharmaceuticals Swiss GmbH scores 68.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.50.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
DISCO Pharmaceuticals Swiss GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
DISCO Pharmaceuticals Swiss GmbH scores 60.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.60.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

DISCO Pharmaceuticals Swiss GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once DISCO Pharmaceuticals Swiss GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

DISCO Pharmaceuticals Swiss GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank DISCO Pharmaceuticals Swiss GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of DISCO Pharmaceuticals Swiss GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 25
8952 Schlieren

At a glance

Legal form
Limited Liability Company
UID
CHE-383.773.555
Founded
2023 · 3 years
Last commercial register change
January 22, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AA
    Athebio AG
    Schlieren
    MA
    Mabylon AG
    Schlieren
    DL
    DAiNA Laboratories AG
    Schlieren
    IB
    InterAx Biotech AG
    Schlieren
    PB
    Proxima Bio GmbH
    Schlieren
    MP
    Molecular Partners AG
    Schlieren
    BA
    Baxiva AG
    Schlieren
    BA
    BiognoSYS AG
    Schlieren